Highlights Economic evidence (cost-effectiveness information) can be used to inform policy-making process in supporting the movement towards universal health coverage. Published literature has focused on methods to set a cost-effectiveness threshold (CET) which can be used to guide the cost-eff

Abstract Background and Objectives The Health Intervention and Technology Assessment Program was commissioned to conduct a cost–utility and budget impact analysis of enzyme replacement therapy (ERT) for Gaucher disease types 1 and 3b. The findings from this assessment are to support the decision-m

Abstract Background and Objectives The Health Intervention and Technology Assessment Program was commissioned to conduct a cost–utility and budget impact analysis of enzyme replacement therapy (ERT) for Gaucher disease types 1 and 3b. The findings from this assessment are to support the decision-m

The study aims to explore how the processes to assess the appropriateness of health technologies are managed and arried out in responsible organizations in other countries. Health technology assessment institutes in 10 countries, amely England, Germany, the Netherlands, Sweden, Denmark, the USA, Canada, Australia, Republic of Korea, and South Afric

Kinanti Khansa Chavarina is an Associate at the International Unit of the Health Intervention and Technology Assessment Program (HITAP) Foundation in Thailand. Her work focuses on health policy and systems research, such as scoping and systematic reviews, qualitative analysis, and economic evaluation. Her research interests include health policy, h

Chronic kidney disease (CKD) is a life-threatening disease for many people. People suffering from such diseases need to undergo some form of kidney replacement therapy in order to live a long life. (1, 2) In 2019, it is estimated that 1.4 million people will die from chronic kidney disease worldwide

November 28, 2017Borneo Bulletin The Independent Newspaper in Brunei published a story of THE Ministry of Health (MoH) through its Office of Policy and Foresight, and in collaboration with the World Health Organization (WHO) organised a two-day training workshop on Health Technology Assessment (HTA)

Open data is widely recognized as valuable, especially during the COVID-19 pandemic, highlighting the need for up-to-date information systems, leading all sectors to acknowledge its significance in enhancing efficiency, fairness, and societal development. These open data movements observed during

The Union of Myanmar is the largest country in mainland South-East Asia with a population of 57.5 million. It has a pluralistic mix of public and private healthcare systems. Although the Ministry of Health (MoH) is the main organisation responsible for healthcare provision, 70-80% of health service expenditure is now absorbed by the households. Thi

In 2008, Myanmar proposed the development of a Health System Strengthening (HSS) programme to the Global Alliance for Vaccines and Immunization (GAVI) and thus received funding and support for its initiative. The HSS framework aimed to shore up three main gaps which were identified: service delivery, programme coordination, and human resources. Ser